中文名 | 5-氨基-1-甲基喹啉-1-鎓碘化物 |
英文名 | 5-Amino-1-methylquinolin-1-ium iodide |
别名 | 化合物NNMTI 5-氨基-1甲基喹啉碘化物 5-氨基-1-甲基喹啉碘代物 5-氨基-1-甲基喹啉-1-碘化物 5-氨基-1-甲基喹啉-1-鎓碘化物 |
英文别名 | NNMTi 5-amino-1MQ 5-Amino-1-methylquinolinium 5-Amino-1methylquinolinium iodide 5-Amino-1-methylquinolin-1-ium iodide 5-amino-1-methylquinolin-1-ium iodide |
CAS | 42464-96-0 |
化学式 | C10H11IN2 |
熔点 | 213-214 °C |
存储条件 | 2-8°C,避光,惰性气体保存 |
MDL号 | MFCD22125886 |
体外研究 | NNMTi (10-30 µM; 96 hours) produces a concentration-related increase in myoblast differentiation on C2C12 myoblast differentiation. 30 µM NNMTi results in 18% MHC-positive myotube nuclei, representing a 45% increase in the extent of myoblast differentiation compared to untreated differentiating myoblasts (12% MHC-positive myotube nuclei). |
体内研究 | NNMTi (subcutaneous (SC) injection; 5 mg/kg and 10 mg/kg; 2 weeks (1 week pre-injury and 1 week post-injury)) has an effect on muscle regeneration after injury, it results in 60% and 75% higher incidence of proliferating/active muSCs at 5 mg/kg and 10 mg/kg, respectively. The relative numbers of fibers with an EdU + myonucleus increased 40% and 48% with NNMTi treatment at 5 mg/kg and 10 mg/kg, respectively. The odds ratio of fused myonuclei for control are 0.58 and 0.53 times the odds at the low and high NNMTi dose, respectively.NNMTi (subcutaneous injection; 10 mg/kg; 1 week) produces no systemic toxicity in mice, the levels of the glucose, cholesterol, plasma proteins, and electrolytes between control and NNMTi-treated samples show no difference in mice. 1-week post-injury daily repeat-dosing of NNMTi is well tolerated with no untoward systemic toxicity or behavioral implications in aged mice. |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!